Chief Medical Officer, Vaxxas
| Role | Organisation | Sources |
|---|---|---|
| Chief Medical Officer | Vaxxas | Brandon Capital, Brandon BioCatalyst, @AuManufacturing |
| Chief Medical Officer (former) | Pfizer | Brandon Capital, Brandon BioCatalyst, @AuManufacturing |
Stories naming Dr Rochelle Chaiken. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Vaxxas hires former Pfizer medical executive Dr Rochelle Chaiken as its chief medical officer; the announcement also recounts the biotech's founding financing and later rounds.
Vaxxas has appointed 23-year Pfizer veteran Dr Rochelle Chaiken as chief medical officer; the announcement also recaps the vaccine-patch company's early backing by OneVentures, Brandon Capital and others.
Vaxxas appointed Dr Rochelle Chaiken, a former Pfizer executive, as Chief Medical Officer, and reported positive interim Phase 1 trial results for its needle-free COVID-19 vaccine patch at the Boston biotech convention.